Salmedix Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

Salmedix General Information

Description

Provider of oncology drug development services intended to serve patients with hematologic malignancies and the biopharmaceutical research community. The company offered clinical-stage cancer therapeutics development (including SDX-105/bendamustine, SDX-101, and SDX-102) and related clinical development programs, thereby advancing treatment options for blood cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 9380 Judicial Drive
  • Suite 160
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Acquirer
Cephalon
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 9380 Judicial Drive
  • Suite 160
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Salmedix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Salmedix‘s full profile, request access.

Request a free trial

Salmedix Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Salmedix‘s full profile, request access.

Request a free trial

Salmedix FAQs

  • When was Salmedix founded?

    Salmedix was founded in 2000.

  • Where is Salmedix headquartered?

    Salmedix is headquartered in San Diego, CA.

  • What industry is Salmedix in?

    Salmedix’s primary industry is Drug Discovery.

  • Is Salmedix a private or public company?

    Salmedix is a Private company.

  • What is the current valuation of Salmedix?

    The current valuation of Salmedix is .

  • What is Salmedix’s current revenue?

    The current revenue for Salmedix is .

  • How much funding has Salmedix raised over time?

    Salmedix has raised $82.6M.

  • Who are Salmedix’s investors?

    Aberdare Ventures, Alexandria Venture Investments, Bio Frontier Partners, Clariden Investment, and Covera Ventures are 5 of 19 investors who have invested in Salmedix.

  • When was Salmedix acquired?

    Salmedix was acquired on 14-Jun-2005.

  • Who acquired Salmedix?

    Salmedix was acquired by Cephalon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process